132 related articles for article (PubMed ID: 22791442)
1. Preparation of nanoparticles by spray-drying and their use for efficient pulmonary drug delivery.
Li HY; Zhang F
Methods Mol Biol; 2012; 906():295-301. PubMed ID: 22791442
[TBL] [Abstract][Full Text] [Related]
2. Preparation of Spray-Dried Nanoparticles for Efficient Drug Delivery to the Lungs.
Li HY; Zhang F
Methods Mol Biol; 2020; 2118():139-145. PubMed ID: 32152976
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle formulations in pulmonary drug delivery.
Bailey MM; Berkland CJ
Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles for drug delivery to the lungs.
Sung JC; Pulliam BL; Edwards DA
Trends Biotechnol; 2007 Dec; 25(12):563-70. PubMed ID: 17997181
[TBL] [Abstract][Full Text] [Related]
5. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Cheow WS; Ng ML; Kho K; Hadinoto K
Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
[TBL] [Abstract][Full Text] [Related]
6. Formulation strategy and use of excipients in pulmonary drug delivery.
Pilcer G; Amighi K
Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
[TBL] [Abstract][Full Text] [Related]
7. Formation, characterization, and fate of inhaled drug nanoparticles.
Zhang J; Wu L; Chan HK; Watanabe W
Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
[TBL] [Abstract][Full Text] [Related]
8. Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.
Hadinoto K; Zhu K; Tan RB
Int J Pharm; 2007 Aug; 341(1-2):195-206. PubMed ID: 17467934
[TBL] [Abstract][Full Text] [Related]
9. Innovative pMDI formulations of spray-dried nanoparticles for efficient pulmonary drug delivery.
Li HY; Xu EY
Int J Pharm; 2017 Sep; 530(1-2):12-20. PubMed ID: 28723410
[TBL] [Abstract][Full Text] [Related]
10. Engineering protein particles for pulmonary drug delivery.
Shoyele SA
Methods Mol Biol; 2008; 437():149-60. PubMed ID: 18369967
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
Pilcer G; Vanderbist F; Amighi K
Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
[TBL] [Abstract][Full Text] [Related]
12. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids.
Hadinoto K; Phanapavudhikul P; Kewu Z; Tan RB
Int J Pharm; 2007 Mar; 333(1-2):187-98. PubMed ID: 17084567
[TBL] [Abstract][Full Text] [Related]
13. Preparation of nanoscale pulmonary drug delivery formulations by spray drying.
Bohr A; Ruge CA; Beck-Broichsitter M
Adv Exp Med Biol; 2014; 811():183-206. PubMed ID: 24683033
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition.
Shen ZG; Chen WH; Jugade N; Gao LY; Glover W; Shen JY; Yun J; Chen JF
Int J Pharm; 2012 Jul; 430(1-2):98-103. PubMed ID: 22486960
[TBL] [Abstract][Full Text] [Related]
15. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
Wang Y; Kho K; Cheow WS; Hadinoto K
Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
[TBL] [Abstract][Full Text] [Related]
16. Effervescent dry powder for respiratory drug delivery.
Ely L; Roa W; Finlay WH; Löbenberg R
Eur J Pharm Biopharm; 2007 Mar; 65(3):346-53. PubMed ID: 17156987
[TBL] [Abstract][Full Text] [Related]
17. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
Rogueda PG; Traini D
Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
[TBL] [Abstract][Full Text] [Related]
18. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
[TBL] [Abstract][Full Text] [Related]
19. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
Chattopadhyay P; Shekunov BY; Yim D; Cipolla D; Boyd B; Farr S
Adv Drug Deliv Rev; 2007 Jul; 59(6):444-53. PubMed ID: 17582648
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary dispersion formulations: the impact of dispersed powder properties on pressurized metered dose inhaler stability.
O'Donnell KP; Williams RO
Drug Dev Ind Pharm; 2013 Mar; 39(3):413-24. PubMed ID: 23216244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]